These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34499691)

  • 21. Does Water Matter? The Impact of Water Vulnerability on Corporate Financial Performance.
    Zheng L; Ye L; Wang M; Wang Y; Zhou H
    Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 Outbreak and Financial Performance of Chinese Listed Firms: Evidence From Corporate Culture and Corporate Social Responsibility.
    Sun Y; Li Y
    Front Public Health; 2021; 9():710743. PubMed ID: 34604155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of green credit policy on the formation of zombie firms: evidence from Chinese listed firms.
    Chen R
    Environ Sci Pollut Res Int; 2022 Nov; 29(53):80669-80682. PubMed ID: 35725881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Firm-level short selling and the local COVID-19 pandemic: Evidence from China.
    He J; Ma X; Wei Q
    Econ Model; 2022 Aug; 113():105896. PubMed ID: 35578633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analyzing the impact of COVID-19 on the performance of listed firms in Saudi market.
    Makni MS
    Technol Forecast Soc Change; 2023 Feb; 187():122171. PubMed ID: 36407787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Impact of the COVID-19 Pandemic on Consumer Behavior-Evidence From China's Stock Market.
    Lu Z; Zhu L; Li X; Li Z
    Front Public Health; 2022; 10():865470. PubMed ID: 36148367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Slack Resources, Corporate Performance, and COVID-19 Pandemic: Evidence from China.
    Jin L; Choi JH; Kim S; Cho K
    Int J Environ Res Public Health; 2022 Nov; 19(21):. PubMed ID: 36361231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The time-varying spillover effect of China's stock market during the COVID-19 pandemic.
    Liu X; Chen Z; Chen Z; Yao Y
    Physica A; 2022 Oct; 603():127821. PubMed ID: 35782685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does corporate environmental investment impede financial performance of Chinese enterprises? The moderating role of financial constraints.
    Akbar A; Jiang X; Qureshi MA; Akbar M
    Environ Sci Pollut Res Int; 2021 Nov; 28(41):58007-58017. PubMed ID: 34101121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19, Urbanization Pattern and Economic Recovery: An Analysis of Hubei, China.
    Yang W; Wang X; Zhang K; Ke Z
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33371455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can R&D investment reduce the impact of COVID-19 on firm performance?-Evidence from India.
    Biswas S
    J Public Aff; 2021 Oct; ():e2773. PubMed ID: 34899063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electricity-consumption data reveals the economic impact and industry recovery during the pandemic.
    Wang X; Si C; Gu J; Liu G; Liu W; Qiu J; Zhao J
    Sci Rep; 2021 Oct; 11(1):19960. PubMed ID: 34620905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ESG performance and stock prices: evidence from the COVID-19 outbreak in China.
    Li Z; Feng L; Pan Z; Sohail HM
    Humanit Soc Sci Commun; 2022; 9(1):242. PubMed ID: 35874283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Research on multiple bubbles in China's multi-level stock market.
    Li G; Xiao M; Yang X; Guo Y; Yang S
    PLoS One; 2021; 16(8):e0255476. PubMed ID: 34339449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CEO Overconfidence, Corporate Governance, and R&D Smoothing in Technology-Based Entrepreneurial Firms.
    Huang Y; Wang X; Li Y; Yu X
    Front Psychol; 2022; 13():944117. PubMed ID: 35910989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association of COVID-19 nexus on China's economy: A financial crisis or a health crisis?
    Hu C; Pan W; Pan W; Dai WQ; Huang G
    PLoS One; 2022; 17(9):e0272024. PubMed ID: 36070293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Governance, financial development and China's outward foreign direct investment.
    Gao C; Wen Y; Yang D
    PLoS One; 2022; 17(6):e0270581. PubMed ID: 35771853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Firms' responses to the COVID-19 pandemic.
    Klöckner M; Schmidt CG; Wagner SM; Swink M
    J Bus Res; 2023 Mar; 158():113664. PubMed ID: 36685011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increasing short-term lending for long-term investment under environmental pressure: evidence from China's energy-intensive firms.
    Xu L; Guo P; Wen H
    Environ Sci Pollut Res Int; 2023 Feb; 30(6):14693-14706. PubMed ID: 36161586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic Importance and Risk Characteristics of Banks Based on a Multi-Layer Financial Network Analysis.
    Gao Q; Fan H; Yu C
    Entropy (Basel); 2024 Apr; 26(5):. PubMed ID: 38785626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.